Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent

Published:2006-03 Issue:3 Volume:41 Page:313-324
ISSN:0020-9996
Container-title:Investigative Radiology
language:en
Short-container-title:Investigative Radiology

Author:

Bourrinet Philippe,Bengele Howard H.,Bonnemain Bruno,Dencausse Anne,Idee Jean-Marc,Jacobs Paula M.,Lewis Jerome M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference23 articles.

1. Liver positive enhancement after injection of superparamagnetic nanoparticles: Respective role of circulating and uptaken particles

2. Superparamagnetic agents: Physicochemical characteristics and preclinical imaging evaluation

3. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes.

4. Evaluation of Neck and Body Metastases to Nodes with Ferumoxtran 10–enhanced MR Imaging: Phase III Safety and Efficacy Study

5. Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer

Cited by 280 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetic resonance imaging-based quantification of endosomal escape using iron oxide nanoparticles-loaded lipid nanoparticles;2024-08-09

2. In vivo study of chelating agent-modified nano zero-valent iron: Biodistribution and toxicity in mice;Water Research;2024-06

3. Revolutionizing lymph node metastasis imaging: the role of drug delivery systems and future perspectives;Journal of Nanobiotechnology;2024-03-29

4. Pharmacokinetic Study of Ultrasmall Superparamagnetic Iron Oxide Nanoparticles HY-088 in Rats;European Journal of Drug Metabolism and Pharmacokinetics;2024-02-23

5. Iron oxide nanoparticles for inflammatory bowel disease: Recent advances in diagnosis and targeted drug therapy;Applied Surface Science Advances;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3